Condition
Mild Alzheimer Disease clinical trials and research
Research outlook What's coming for Alzheimer's disease: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Mild Alzheimer Disease clinical trials that are recruiting, at sites in 2 countries (most in China (1), United States (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Photobiomodulation therapy for mild cognitive impairment and mild Alzheimer's disease
This trial tests whether daily transcranial near-infrared light therapy, versus a sham device, can improve cognitive function in adults with mild cognitive impairment or mild Alzheimer's disease.
-
Siponimod to slow brain shrinkage in early Alzheimer's
This 18-month study will test whether siponimod can slow brain shrinkage and change Alzheimer’s biomarkers in people with mild Alzheimer's disease.
Related topics
Quick answers
How many Mild Alzheimer Disease clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.